From March 10, 2022 to June 10, 2022, the company has repurchased 519,451 shares, representing 1.01% for KRW 10,000.02 million. With this, the company has completed the repurchase of 519,451 shares, representing 1.01% for KRW 10,000.02 million under the buyback announced on March 10, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
33,500 KRW | -1.90% |
|
+6.18% | -24.38% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.38% | 1.26B | |
+47.27% | 765B | |
-6.77% | 354B | |
+19.48% | 331B | |
+8.69% | 299B | |
+18.87% | 248B | |
-1.96% | 219B | |
+11.11% | 216B | |
+4.79% | 164B | |
-2.62% | 162B |
- Stock Market
- Equities
- A009420 Stock
- News Hanall Biopharma Co., Ltd.
- Tranche Update on Hanall Biopharma Co.,Ltd's Equity Buyback Plan announced on March 10, 2022.